Cardioloxía

2018

1. 1-Year Clinical Outcomes of All-Comer Patients Treated With the Dual-Therapy COMBO Stent: Primary Results of the COMBO Collaboration

   JACC: Cardiovascular Interventions, Vol. 11, Núm. 19, pp. 1969-1978

2. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents

   JACC: Cardiovascular Interventions, Vol. 11, Núm. 10, pp. 981-991

3. A multicentre randomized pilot trial on the effectiveness of different levels of cooling in comatose survivors of out-of-hospital cardiac arrest: the FROST-I trial

   Intensive Care Medicine, Vol. 44, Núm. 11, pp. 1807-1815

4. A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: Six-month angiographic and one-year clinical results of the NIREUS trial

   EuroIntervention, Vol. 14, Núm. 1, pp. 86-93

5. ASB1 differential methylation in ischaemic cardiomyopathy: Relationship with left ventricular performance in end-stage heart failure patients

   ESC Heart Failure, Vol. 5, Núm. 4, pp. 732-737

6. Acute and long-term outcomes of simultaneous atrioventricular node ablation and leadless pacemaker implantation

   PACE - Pacing and Clinical Electrophysiology, Vol. 41, Núm. 11, pp. 1484-1490

7. Acute muscle fatigue and CPR quality assisted by visual feedback devices: A randomized-crossover simulation trial

   PLoS ONE, Vol. 13, Núm. 9

8. Advanced heart failure: The new HFA consensus definition

   Dialogues in Cardiovascular Medicine, Vol. 23, Núm. 2, pp. 69-73

9. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology

   European Journal of Heart Failure, Vol. 20, Núm. 11, pp. 1505-1535

10. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529

11. Alirocumab and cardiovascular outcomes after acute coronary syndrome

    New England Journal of Medicine, Vol. 379, Núm. 22, pp. 2097-2107

12. An Easy Assessment of Frailty at Baseline Independently Predicts Prognosis in Very Elderly Patients With Acute Coronary Syndromes

    Journal of the American Medical Directors Association, Vol. 19, Núm. 4, pp. 296-303

13. Anatomical and clinical predictors of valve dysfunction and aortic dilation in bicuspid aortic valve disease

    Heart, Vol. 104, Núm. 7, pp. 566-573

14. Anatomical and procedural predictors of pulmonary vein stenosis in the setting of second-generation cryoballoon ablation

    Journal of Cardiovascular Medicine, Vol. 19, Núm. 6, pp. 290-296

15. Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry

    Thrombosis Research, Vol. 167, pp. 142-148

16. Aortic Coarctation With Extensive Collateral Circulation

    Circulation. Cardiovascular imaging, Vol. 11, Núm. 8, pp. e007918

17. Assessing the performance of the PRECISE-DAPT and Paris risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients

    EuroIntervention, Vol. 13, Núm. 16, pp. 1914-1922

18. Association Between Ischemic and Bleeding Risk Scores and the Use of New P2Y12 Inhibitors in Patients With Acute Coronary Syndrome

    Revista Espanola de Cardiologia, Vol. 71, Núm. 7, pp. 538-544

19. Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry

    American Journal of Cardiovascular Drugs, Vol. 18, Núm. 4, pp. 299-309

20. Automatic multiscale vascular image segmentation algorithm for coronary angiography

    Biomedical Signal Processing and Control, Vol. 46, pp. 1-9